Cobalamin-dependent methionine synthase (MetH) is a modular protein that catalyzes the transfer of a methyl group from methyltetrahydrofolate to homocysteine to produce methionine and tetrahydrofolate. The cobalamin cofactor, which serves as both acceptor and donor of the methyl group, is oxidized once every Ϸ2,000 catalytic cycles and must be reactivated by the uptake of an electron from reduced flavodoxin and a methyl group from Sadenosyl-L-methionine (AdoMet). Previous structures of a C-terminal fragment of MetH (MetH CT ) revealed a reactivation conformation that juxtaposes the cobalamin-and AdoMet-binding domains. Here we describe 2 structures of a disulfide stabilized MetH CT (S-SMetH CT ) that offer further insight into the reactivation of MetH. The structure of S-SMetH CT with cob(II)alamin and Sadenosyl-L-homocysteine represents the enzyme in the reactivation step preceding electron transfer from flavodoxin. The structure supports earlier suggestions that the enzyme acts to lower the reduction potential of the Co(II)/Co(I) couple by elongating the bond between the cobalt and its upper axial water ligand, effectively making the cobalt 4-coordinate, and illuminates the role of Tyr-1139 in the stabilization of this 4-coordinate state. The structure of S-SMetH CT with aquocobalamin may represent a transient state at the end of reactivation as the newly remethylated 5-coordinate methylcobalamin returns to the 6-coordinate state, triggering the rearrangement to a catalytic conformation.
C
obalamin-dependent methionine synthase (MetH) is a modular enzyme (1) that catalyzes methyl transfer from methyltetrahydrofolate (CH 3 -H 4 folate) to homocysteine (Hcy), forming tetrahydrofolate (H 4 folate) and methionine. The enzyme from Escherichia coli is one of the best-studied members of a large class of cobalamin-and corrinoid-dependent methyltransferases (2) . In this class of enzymes, the cobalamin cofactor plays a crucial role in catalysis, acting both as a methyl donor and acceptor. During the MetH reaction cycle the methylcobalamin form of the cofactor [MeCo(III)Cbl] is demethylated by Hcy. The electrons of the carbon-cobalt bond remain on the cofactor producing cob(I)alamin [Co(I)Cbl]. Co(I)Cbl is subsequently remethylated by CH 3 -H 4 folate regenerating the MeCo(III)Cbl cofactor (Fig. 1A) . However under aerobic conditions, the cobalamin cofactor is oxidized to an inactive cob(II)alamin [Co(II)Cbl] form about once in every 2,000 turnovers (3) . To avoid accumulation of this inactive species, the enzyme undergoes a reductive reactivation, in which Co(II)Cbl is reduced to Co(I)Cbl with an electron supplied by flavodoxin (Fld), and Co(I)Cbl is then remethylated using S-adenosylmethionine (AdoMet) (4, 5) . Reductive reactivation is a challenging reaction because the reduction potential of Co(II)Cbl in solution is out of the range of physiological reducing agents (6) (7) (8) .
MetH has 4 functional units that bind Hcy, CH 3 -H 4 folate, Cbl, and AdoMet, respectively (1) . During catalysis and reactivation, the appropriate substrate-binding module must be positioned close to the cobalamin to allow methyl transfer. A major challenge is to understand what guides the enzyme through its complex conformational changes without permitting futile cycling. Although the structure of the full-length enzyme has not yet been determined, there are structures of the individual cobalamin-binding (9) and AdoMet-binding modules (10) from E. coli. In addition, 2 multimodular fragments have been characterized: an N-terminal polypeptide (Hcy and CH 3 -H 4 folate modules) from Thermotoga maritima (11, 12 ) and a C-terminal polypeptide (cobalamin and AdoMet modules) from E. coli (12, 13) . During catalysis the enzyme cycles between conformations in which the cobalamin-binding module is juxtaposed alternatively with the Hcy-binding module and the CH 3 -H 4 folatebinding module, whereas for the reductive reactivation the enzyme assumes a conformation in which the cobalamin-binding module is juxtaposed with the AdoMet-binding module. Access to this reactivation conformation is rigorously controlled to This article contains supporting information online at www.pnas.org/cgi/content/full/ 0906132106/DCSupplemental. avoid futile cycling (14) . A major factor in controlling access to the catalytic and reactivation cycles of the enzyme is the coordination of the Cbl, which in turn is responsive to the positive charge and the oxidation state of the Co.
The free Co(II)Cbl cofactor in solution is 5-coordinate, with a nitrogen ligand in the lower axial coordination site. In this state, a N atom of the dimethylbenzimidazole nucleotide substituent of the corrin macrocycle is directly coordinated to the Co atom resulting in an intramolecular linkage (Fig. 1B) . At pH values Ͻ2.9, where the dimethylbenzimidazole is protonated and dissociates, it is replaced by a water ligand with the resulting shift of the reduction potential from -610 mV to Ϫ500 mV (6) .
When MeCo(III)Cbl is bound to MetH, the dimethylbenzimidazole ligand that is coordinated to the cobalt in the free cofactor is displaced by a histidine from the cobalamin-binding domain (H759 in E. coli MetH) (9) (Fig. 1C) . As shown in Fig.  1D , MeCo(III)Cbl, Co(II)Cbl, and Co(I)Cbl differ in their preferred coordination states. In particular, the affinity of the cobalt for a nitrogen ligand in the lower axial position is directly proportional to the net positive charge on the cobalt (15) (16) (17) . Entrance into the reactivation conformation is associated with dissociation of the histidine ligand from the Co(II)Cbl (18, 19) .
We previously described the generation of a C-terminal fragment of MetH (MetH CT ) that contains the Cbl-and AdoMet-binding modules (18) . In the MeCo(III)Cbl form this fragment undergoes temperature-dependent spectral changes, indicating that it interconverts between forms in which H759 is coordinated to the cobalt (His-on) or dissociated (His-off). To reduce conformational flexibility a disulfide cross-link was introduced by mutating Ile-690 and Gly-743 to cysteines ( S-S MetH CT ). The X-ray structure of the MeCo(III)Cbl form of S-S MetH CT revealed that the MeCo(III)Cbl cofactor had been photolyzed by the X-ray beam during data collection, and that the cobalt appeared 4-coordinate with no electron density evident for the methyl group (12) . Four-coordinate Co(II)Cbl has never been observed in aqueous solution. Follow-up studies by Brunold and coworkers (20) of the Co(II)Cbl form of S-S MetH CT using a variety of spectroscopic approaches revealed that the Co(II)Cbl form of the isolated S-S MetH CT is 5-coordinate, with an axially coordinated water molecule. Following addition of AdoMet to S-S MetH CT , the Co-OH 2 bond is dramatically lengthened such that the Co(II)Cbl is effectively 4-coordinate.
The work presented here explores the mechanisms by which MetH CT stabilizes the 4-coordinate form of Co(II)Cbl. The structure of a binary complex of S-S MetH CT in the Co(II)Cbl form with adenosylhomocysteine (AdoHcy) has been determined, revealing that Y1139 facilitates the lengthening of the Co-OH 2 distance such that the cobalamin is effectively 4-coordinate. This is corroborated by the mutation of Y1139 to phenylalanine (Y1139F), which lowers the reduction potential from Ϫ490 mV to Ϫ540 mV. We have also examined the surprising finding that S-S MetH CT remains capable of converting between His-on and His-off states, even though its conformational flexibility is greatly reduced by the disulfide cross-link. We present an X-ray structure of the aquocobalamin [AquoCo(III)Cbl] form of S-S MetH CT , which crystallizes in the same conformation as the His-off MeCo(III)Cbl S-S MetH CT and which spectral studies show to be His-on. This His-on form may resemble a transient intermediate in the reductive reactivation of the enzyme. Table S1 . This is the first structure to reveal the positioning of an AdoMet analogue with respect to the cobalamin cofactor in the reactivation complex (Fig. 2) . AdoHcy was built into clear electron density at 2.7 Å resolution following molecular replacement and initial refinement without a bound ligand (Fig. 2) . The orientation of the AdoHcy and its interactions with the activation domain are essentially the same as those of the AdoMet in the structure of its excised binding domain (10) .
Results
The environment of the Co(II)Cbl cofactor represents the state of the enzyme as it is ready to accept an electron from Fld ( Fig. 3) , and in this structure the cobalt appears to be 4-coordinate. H759, the lower axial ligand in other forms of MetH, is dissociated and interacts with the AdoMet domain, with no evidence for a water or any other ligand in the upper or lower axial position. However, density near the upper axial position was assigned to a water molecule stabilized by a hydrogen bond with the side chain of E1097. Compared to the previously determined structure of the MeCo(III)Cbl form (12) , the side chain of E1097 is repositioned by AdoHcy binding, allowing formation of a hydrogen bond to the water molecule. Moreover, the distance between the cobalt and the Y1139 OH moiety has decreased from 4.5 Å to 4.0 Å. A model methyl group was added to the AdoHcy (Fig. S1 ), but the resulting Co-Me distance of 5.3 Å and the position of Y1139 between Cbl and AdoHcy suggest that further conformational changes would be necessary to accomplish methyl transfer.
Effect of a Y1139F Mutation on Cbl Reduction Potential. To determine the role of Y1139 in the generation of the Co(I)Cbl intermediate, a Y1139F/I690C/G743C triple mutant was constructed ( S-S MetH CT /Y1139F). The Y1139F mutation was incorporated into the double mutant background (I690C/G743C). We measured the reduction midpoint potentials of the Co(II) in both the double ( S-S MetH CT ) and triple mutant ( S-S MetH CT /Y1139F) constructs ( Fig. 4 A and B) . The Co(II)/Co(I) Cbl midpoint potential was Ϫ490 mV for S-S MetH CT , a value identical to that reported for the full-length wild-type enzyme. In contrast, the potential was lowered to Ϫ540 mV for the S-S MetH CT /Y1139F mutant ( Fig. 4 C and D) . This result can be rationalized in the context of the S-S MetH CT structure with AdoHcy bound (Fig. 3) . The hydrogen bond between the Y1139 OH and the axial water observed in the structure cannot form in S-S MetH CT /Y1139F, which could thus impede the formation of 4-coordinate Co(II)Cbl and subsequent reduction of the Co(II) to Co(I)Cbl. The 50-mV decrease in reduction potential of S-S MetH CT /Y1139F is consistent with the theoretical prediction that a hydrogen bond between water and the Y1139 OH should increase the reduction potential (20) . Table S1 ). These crystals do not contain the substrate/ product (AdoMet/AdoHcy). The relative domain arrangement in the AquoCo(III)Cbl S-S MetH CT structure (Fig. S2 ) is similar to those observed in previous structures of MetH CT fragments ( Fig. 2) (12, 13) . Relative to other MetH CT structures, the AquoCo(III)Cbl S-S MetH CT structure has 3 distinct features ( Fig. 5 A and B) : (i) H759 returns to a position below the cobalt (His-on) with adjustments in the surrounding loops; (ii) Y1139 moves away from the cobalt; and (iii) the cobalamin domain exhibits a small rigid body motion relative to the reactivation domain and the corrin ring.
In solution and in the crystals used for structure determination, AquoCo(III)Cbl S-S MetH CT is red, indicating that histidine is coordinated to the cobalt. This is consistent with the His-on position of electron density for the H759 side chain. However, crystallographic refinement consistently resulted in a long distance (Ϸ3.4 Å) from the cobalt to N2 of H759. The most likely explanation for the long bond is photoreduction of the Co(III) in the X-ray beam, as seen in other Co(III)Cbl structures (12, 21) . Density for the Y1139 side chain indicates partial disorder, but nonetheless clear evidence of movement away from the cobalamin toward the empty AdoHcy/AdoMet binding pocket. The AquoCo(III)Cbl axial water ligand was omitted from the original model, but following refinement, prominent density above the Co atom was assigned to a water ligand. After further refinement, the 2.1-Å distance is consistent with water coordination to the Co atom.
Comparison of the AquoCo(III)Cbl S-S MetH CT structure with the structure of the MeCo(III)Cbl form of S-S MetH CT (PDB ID 3BUL) (12) reveals a small but significant shift of the cobalamin domain relative to the AdoMet domain (Fig. 5B, Fig. S2 ). When the AdoMet domains of the 2 structures are aligned, the average motion of the cobalamin domain is Ϸ1 Å, with a maximum displacement of 2.1 Å at the outer edge. Surprisingly, the corrin ring system does not move with its binding domain but maintains its position relative to the AdoMet domain.
Discussion
Activation for Electron Transfer. In the absence of the protein scaffold, the reduction potential for a 5-coordinate Co(II)Cbl cofactor is thermodynamically unfavorable relative to those of physiological reductants. Thus, the occasional oxidation to the Co(II) state should result in very low concentrations of Co(I)Cbl at equilibrium, and extremely slow rates of reduction and subsequent methylation by AdoMet. In conjunction with recently reported spectroscopic data (20) , the structure of the Co(II)Cbl S-S MetH CT provides a clear picture of how MetH is able to move the potential of the Co(II)Cbl/Co(I)Cbl couple into the physiological range. The enzyme elongates the Co-H 2 O bond to a formally 4-coordinate species, thereby raising the reduction potential of Co(II)Cbl (20, 22) , and facilitating reduction by the physiological partner Fld. Fig. 3 presents the crystal structure of S-S MetH CT in the conformation required for Co-H 2 O bond elongation. This structure reveals that elongation of the Co-H 2 O bond is enabled by the contributions of 2 invariant residues, Y1139 and E1097 (sequence alignment shown in Fig. S3 ). Following AdoMet/AdoHcy binding, these amino acids are repositioned to interact with the water molecule that was coordinated to Co in the 5-coodinate Co(II)Cbl species as seen in Fig. 3 . Comparison of this structure to previously reported structures of MetH CT (12, 13) in absence of the AdoMet cofactor indicates that the Y1139/E1097 water-binding pocket is formed only when the AdoMet/AdoHcy cofactor is present. In the previous structures, E1097 was oriented differently, and only in the present structure it is poised to interact with the water molecule (Fig. 5) . Further evidence for the repositioning of E1097 following AdoMet binding is found in the structure of the isolated MetH reactivation domain with AdoMet bound, in which the E1097 is pointed toward the water-binding pocket (10) . The reduction potential of Y1139F S-S MetH CT is lowered and reduction of Co(I-I)Cbl by Fld becomes less favorable. The effects of the Y1139F mutation can be rationalized in the context of the structure and the proposed reactivation cycle (Fig. 6) . The structure reveals that the AdoMet ribose moiety is perpendicular to the Y1139 aromatic group with the ribose ring oxygen pointing directly toward the center of the -aromatic cloud. This interaction allows Y1139 to move closer to the Co atom (Co/Y-OH distance 4.0 Å), and positions it for a hydrogen bonding interaction to the water formerly bound to Co. The importance of Y1139 in lowering the reduction potential via this mechanism is corroborated by spectroscopic data (20) .
Structural superpositions of the available C-terminal S-S MetH fragments demonstrate that the position of Y1139 varies significantly between structures (Fig. S4) . In the absence of the AdoMet/AdoHcy ligand, the distance between the hydroxyl of Y1139 and the cobalt increases and the tyrosyl ring approaches the binding site for the adenosine of AdoHcy (Fig. 5B) . The binding of AdoMet allows Y1139 to move closer to the water ligand and the Co atom, thus enabling the elongation of the H 2 O-Co bond. This strained state would not be possible in the absence of AdoMet or its analogue AdoHcy. This elegant safety mechanism discourages futile electron transfer from Fld, in the absence of AdoMet.
Rearrangement Following Methyl Transfer. When MetH enters the reactivation conformation, H759 dissociates from the cobalamin and forms a hydrogen bond with D1093 in the AdoMet domain that stabilizes this conformation (11, 12) . Following reduction and methyl transfer, a 5-coordinate MeCo(III)Cbl species is formed (Fig. 6) . We propose that this species is in a conformation similar to the Co(II)Cbl structure presented here [Intermediate conformation (2 or 6) in Fig. 6 ]. After methyl transfer, the affinity of H759 for the cobalt of MeCo(III)Cbl increases (17) and allows H759 to break its interaction with the AdoMet domain and bind to Co. However, a domain motion is required to position H759 to bind the cobalt. A comparison of the Co(II)Cbl and AquoCo(III)Cbl structures provides insight into this domain motion. The AquoCo(III)Cbl structure represents an open conformation (Figs. 5, 6, Fig. S2 ) in which the cobalamin domain has moved away from the AdoMet domain to allow for H759 coordination. The formation of AquoCo(III)Cbl S-S MetH CT permits us to trap the enzyme in this open conformation that mimics the last step of the reactivation cycle (Fig. 6 ).
Conclusions
Our findings emphasize the importance of the coordination state of the cobalamin cofactor in governing entrance into and exit from the reactivation conformation. We propose a tug of war between coordination of H759 by the cobalt of Cbl and its participation in intramodular hydrogen bonding interactions. We have previously proposed that when cob(I)alamin is formed during the catalytic cycle, such intramodular interactions are formed between H759 and the CH 3 -H 4 folate module, locking the enzyme into this conformation until methyl transfer has occurred (12) . The increased positive charge on cobalt following either methyl transfer or oxidation would allow breakage of these intramodular bonds and recoordination of H759 to the cobalt, allowing conformational transitions. In the case of reactivation, the binding of Fld (19) and AdoMet then shift the equilibrium to favor histidine dissociation and stabilization of the reactivation conformation by intramodular hydrogen bonding to D1093 in the AdoMet module (12), allowing reduction of Co(II)Cbl and subsequent methyl transfer from AdoMet. The increased positive charge on MeCo(III)Cbl then allows breakage of the intramodular bonds and recoordination of H759, which in turn permits a conformational transition to the catalytic cycle.
Methods
Chemicals/Cofactors. AdoMet, glycerol, hydrochloric acid (HCl), 2,2,6,6-tetramethylpiperidine-1-oxyl, MeCbl, and potassium ferricyanide were purchased from Sigma-Aldrich and used without further purification. The 5-deazaflavin-3-sulfonate was a gift from the late Vincent Massey (University of Michigan). E. coli Fld was purified according to published procedures (23, 24) . CT and Y1139F S-S MetH CT . The I690C/G743C double mutation was introduced into the pVB8 vector containing an amino-terminal His 6-tagged E. coli wild-type C-terminal MetH, using the QuikChange site-directed mutagenesis kit (Stratagene). The primers were obtained from Invitrogen). The sequence was confirmed by complete sequencing at the Biomedical Research Core Facility of the University of Michigan. The resulting plasmid was named pSD-3.
Construction of an Expression Plasmid for S-S MetH
The Y1139F mutation was introduced into pSD-3 by ligation of a fragment of DNA from the pCS-15 vector containing the mutation. Briefly, pCS-15 was digested with HindIII and BbvcI at 37°C. The 330-bp fragment was purified from an agarose gel and ligated into the similarly digested pSD-3 vector, yielding pSD-4. The presence of this mutation was verified by sequencing at the Biomedical Research Core Facility of the University of Michigan.
Expression and Purification of S-SMetH
CT and Y1139F S-SMetH CT . The enzymes were expressed in cells of E. coli Hms174(DE3) (Novagen) and purified by nickel affinity chromatography using a 5-mL Hi-trap and a MonoQ 16/10 column (Amersham Biosciences).
Reduction and Photolysis of Cbl Bound to S-SMetH
CT . S-SMetH CT was converted to the MeCo(III)Cbl form through reductive methylation by AdoMet in an electrochemical cell. The Co(II)Cbl-bound MetH forms were generated via photolysis of the corresponding MeCo(III)Cbl-bound species, as described previously (25) . Protein concentrations were determined spectrophotometrically by using the extinction coefficients of the enzyme-bound MeCo(III)Cbl cofactor ( 452[S-SMetH CT ] ϭ 10.2 mM Ϫ1 cm Ϫ1 ) (26) . The AquoCo(III)Cbl forms of the mutants were prepared by treating the enzyme with 50 M of potassium ferricyanide in 10 mM phosphate buffer, pH 7.2 in a cuvette immersed in ice-water and exposing to a tungsten-halogen lamp (650W) at a distance of 5 cm. The formation of the aquo species was monitored in a spectrophotometer (352 nm) for completion of the reaction. The excess reagents were removed by the use of a gel filtration column. Protein concentrations were determined spectrophotometrically by using the extinction coefficients of the enzyme- Spectrophotometric Determination of the Co(II)/Co(I)Cbl Midpoint Potential. The midpoint potential was measured as described previously (3) . A 1-mL solution of 30 M enzyme, 100 M methyl viologen, and 5 M 5-deazaflavin-3-sulfonate in buffer (100 mM potassium phosphate, 100 mM KCl, and 25 mM EDTA, pH 7.2) was equilibrated with Ar(g) in an anaerobic glass cuvette. The enzyme was reduced by irradiation with a 600 W tungsten/halogen lamp, and the slow oxidation at 37°C was monitored by absorption spectroscopy. The concentration of reduced methyl viologen was calculated on the basis of the absorbance at 600 nm ( 600 ϭ 13,600 M Ϫ1 cm Ϫ1 ) (27) , taking into account that the enzyme also weakly absorbs at this wavelength. These values were used in the Nernst equation, along with the midpoint potential for methyl viologen (Ϫ446 mV vs. SHE), to calculate the system potential at each time point. Then, the absorbance at 468 nm was corrected for contributions from methyl viologen and used to calculate the concentrations of Co(II)Cbl Data Collection and Structure Determination. Diffraction data were collected at GM/CA-CAT IDB (APS) on a Mar300 detector and processed with XDS (28) . Phases for both data sets were obtained by molecular replacement using the individual protein domains of the S-SMetH CT :MeCo(III)Cbl structure (PDB ID 3BUL). EPMR (29) was used to determine initial phases for the S-S MetH CT :Co(II)Cbl:AdoHcy structure, and the AutoMR routine of the PHENIX package (30) was used to determine the AquoCo(III)Cbl phases. Initial density allowed for cofactors/ligand to be added. Both structures were refined with CNS (31) including rigid body refinement of the individual domains followed by simulated annealing in torsional space, coordination minimization, and restrained individual B-factor adjustment with maximum-likelihood targets. CNS recognized and restrained the disulfide between C690 and C743. To eliminate bias in the S-SMetH CT :AquoCo(III)Cbl structure, both H759 and Y1139 were replaced with alanine in the model used for molecular replacement and waters were omitted. Positive electron density below the cobalamin ring indicated the presence of the histidine side chain, but after H759 was modeled and refined, the distance from the cobalt to N2 of H759 was 3.4 Å. The histidine is in the expected ''on'' location, but too far from the cobalt to be considered coordinated (Fig. 5A, Fig. S5 ). To determine whether this could be an artifact of relatively low resolution, the refinement was repeated with the Co-N2 bond restrained to 2.0 Å. The resulting difference maps show negative density at the new position of the histidine ring verifying the long N2-Co distance and confirming that the original histidine was modeled properly. Model modification was performed with Coot (32) , and the geometric quality of the model and its agreement with the structure factors were assessed with MolProbity (33) . Figs. 1 B and C, 2-5 , S1, S2, S4, and S5 were generated with PyMOL (34) .
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